Stay updated with breaking news from Meng Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among patients with a history of ischemic stroke, more intensive LDL-C-lowering statin-based therapies are associated with a decreased risk for recurrent stroke.
The effect was not seen for patients without atherosclerosis, leading some to question the need for treatment in that group.
Taiwan: A recent study published in the Journal of American Medical Association - Neurology pointed out that, more intensive LDL-C–lowering statin-based therapies might be warranted for patients with...
More intensive LDL-C-lowering with statin-based therapies linked to reduced risk for recurrent stroke for patients with evidence of atherosclerosis.
TUESDAY, Feb. 22, 2022 (HealthDay News) — Among patients with a history of ischemic stroke, more intensive low-density lipoprotein cholesterol (LDL-C)-lowering statin-based therapies are associated with a decreased risk for recurrent stroke but an increased risk for hemorrhagic stroke, according to a meta-analysis published online Feb. 21 in JAMA Neurology. Meng Lee, M.D., from the […]